550
K. Bahrami et al.
PAPER
2-Phenyl-1H-benzimidazole (Table 1, Entry 1)
Amorphous beige solid.
References
(1) Tebbe, M. J.; Spitzer, W. A.; Victor, F.; Miller, S. C.; Lee,
C. C.; Sattelberg, T. R.; Mckinney, E.; Tang, C. J. J. Med.
Chem. 1997, 40, 3937.
(2) (a) Porcari, A. R.; Devivar, R. V.; Kucera, L. S.; Drach, J. C.;
Townsend, L. B. J. Med. Chem. 1998, 41, 1251. (b) Roth,
M.; Morningstar, M. L.; Boyer, P. L.; Hughes, S. H.;
Bukheit, R. W.; Michejda, C. J. J. Med. Chem. 1997, 40,
4199.
(3) Migawa, M. T.; Giradet, J. L.; Walker, J. A.; Koszalka, G.
W.; Chamberlain, S. D.; Drach, J. C.; Townsend, L. B. J.
Med. Chem. 1998, 41, 1242.
(4) Tamm, I.; Seghal, P. B. Adv. Virus Res. 1978, 22, 187.
(5) Tamm, I. Science 1957, 126, 1235.
(6) Mann, J.; Baron, A.; Opoku-Boahen, Y.; Johansson, E.;
Parkinson, G.; Kelland, L. R.; Neidle, S. J. Med. Chem.
2001, 44, 138.
(7) (a) Bouwman, E.; Driessen, W. L.; Reedijk, J. Coord. Chem.
Rev. 1990, 104, 143. (b) Pujar, M. A.; Bharamgoudar, T. D.
Transition Met. Chem. 1988, 13, 423.
(8) (a) Bai, Y.; Lu, J.; Shi, Z.; Yang, B. Synlett 2001, 544.
(b) Hasegawa, E.; Yoneoka, A.; Suzuki, K.; Kato, T.;
Kitazume, T.; Yangi, K. Tetrahedron 1999, 55, 12957.
(9) Sazen, B.; Sames, D. Org. Lett. 2003, 5, 3607.
(10) Matsushita, H.; Lee, S. H.; Joung, M.; Clapham, B.; Janda,
K. D. Tetrahedron Lett. 2004, 45, 313.
IR (KBr): 3248, 1683, 1648, 1580, 1523, 1302 cm–1.
1H NMR (200 MHz, DMSO-d6): d = 7.54 (m, 2 H), 7.75 (m, 3 H),
7.85 (m, 2 H), 8.3 (m, 2 H).
13C NMR (50 MHz, DMSO-d6): d = 114.2, 123.9, 125.7, 128.0,
129.8, 132.5, 133.0, 149.5.
4-(1H-Benzimidazol-2-yl)-N,N-dimethylaniline (Table 1, Entry
4)
Amorphous pale-yellow solid.
IR (KBr): 3380, 1618, 1590, 1484, 1456, 1420 cm–1.
1H NMR (200 MHz, DMSO-d6): d = 3.1 (s, 3 H), 6.9 (d, J = 9.2 Hz,
2 H), 7.5 (m, 2 H), 7.2 (m, 2 H), 8.06 (d, J = 9.2 Hz, 2 H).
13C NMR (50 MHz, DMSO-d6): d = 39.5, 107.8, 111.8, 113.2,
125.1, 129.1, 131.5, 149.8, 153.2.
5-Methyl-2-phenyl-1H-benzimidazole (Table 1, Entry 11)
Amorphous pale-yellow solid.
IR (KBr): 3376, 1619, 1596, 1488, 1456, 1356, 1340 cm–1.
1H NMR (200 MHz, DMSO-d6): d = 2.5 (s, 3 H), 7.4 (m, 1 H), 7.6
(s, 1 H), 7.75 (m, 4 H), 8.25 (m, 2 H).
13C NMR (50 MHz, DMSO-d6): d = 21.2, 113.4, 113.7, 123.5,
127.4, 127.8, 129.6, 130.3, 132.4, 133.0, 134.0, 148.7.
(11) Lewis, J. C.; Wiedemann, S. H.; Bergman, R. G.; Ellman, J.
A. Org. Lett. 2004, 6, 35.
5-Nitro-2-[4-(5-nitro-1H-benzimidazol-2-yl)phenyl]-1H-benz-
imidazole (Table 1, Entry 23)
Amorphous brown solid.
IR (KBr): 3250, 1630, 1513, 1342 cm–1.
1H NMR (200 MHz, DMSO-d6, TFA): d = 8.45 (s, 2 H), 8.2 (d, J =
8.4 Hz, 2 H), 8.1 (m, 2 H), 7.9 (m, 2 H), 7.7 (d, J = 8.4 Hz, 2 H).
(12) Pranjal, G.; Dilip, K. Tetrahedron Lett. 2006, 47, 79.
(13) Songnian, L.; Lihu, Y. Tetrahedron Lett. 2005, 46, 4315.
(14) Preston, P. N. Benzimidazoles, Congeneric Tricyclic
Compounds, In Chemistry of Heterocyclic Compounds, Part
1, Vol. 40; Weissberger, A.; Taylor, E. C., Eds.; Wiley: New
York, 1981, 6.
(15) Grimmet, M. R. Imidazoles and their Benzo Derivatives, In
Comprehensive Heterocyclic Chemistry, Vol. 5; Katritzky,
A. R.; Ress, C. W., Eds.; Pergamon: Oxford, 1984, 457.
(16) Wang, Y.; Sarris, K.; Sauer, D. R.; Djuric, S. W.
Tetrahedron Lett. 2006, 47, 4823.
13C NMR (50 MHz, DMSO-d6, TFA): d = 150.8, 111.4, 135.7,
122.1, 115.5, 146.5, 131.8, 122.6, 133.4, 134.6.
Acknowledgment
(17) Benincori, T.; Sannicolo, F. J. Heterocycl. Chem. 1998, 25,
1029.
(18) Daniel, R. B.; de Visser, S. P.; Shaik, S.; Neumann, R. J. Am.
Chem. Soc. 2003, 125, 12116.
We are thankful to the Razi University Research Council for partial
support of this work.
Synthesis 2007, No. 4, 547–550 © Thieme Stuttgart · New York